首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Influenza A Virus Hemagglutinin HA2 Subunit Recombinant Antibody

Anti-Influenza A Virus Hemagglutinin HA2 Subunit Recombinant Antibody

产品编号

YR1335

别名

科研级 Diridavumab ( 地利伏单抗 ), Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab

规格
  • 1mg
  • 5mg
产品介绍
Catalog NumberYR1335
Alias科研级 Diridavumab ( 地利伏单抗 ), Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab
Size1mg, 5mg
Molecular NameDiridavumab
CAS Number1393659-46-5
TargetInfluenza A Virus Hemagglutinin HA2 Subunit from Various Strains[Influenza A Virus]
Antibody IsotypeIgG1 Lambda
ClonityMonoclonal
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundDiridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.
ApplicationFCM
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价